未登录.png)
分享.png)
收藏分享 收藏 Single-arm multicenter phase II study on aggressive local consolidative therapy in combination with systemic chemotherapy for stage IV non-small cell lung carcinoma with oligometastases: CURE-OLIGO (TORG1529)
Tokito, Takaaki; Yamada, Kazuhiko; Ishii, Hidenobu; Takiguchi, Yuichi; Saito, Go; Minato, Koichi; Imai, Hisao; Tanaka, Hiroshi; Miura, Satoru; Watanabe, Kageaki; Koreeda, Yoshifusa; Ono, Akira; Furuya, Naoki; Misumi, Toshihiro; Hayakawa, Kazushige; Ogo, Etsuyo; Okamoto, Hiroaki 分享 收藏 Prevalence and Risk Factors of Constipation Symptoms among Patients Undergoing Colonoscopy: A Single-Center Cross-Sectional StudyKomori, Shiori; Akiyama, Junichi; Tatsuno, Naoko; Yamada, Erika; Izumi, Atsuko; Hamada, Mariko; Seto, Kana; Nishiie, Yuriko; Suzuki, Keigo; Hisada, Yuya; Otake, Yuki; Yanai, Yuka; Okubo, Hidetaka; Watanabe, Kazuhiro; Akazawa, Naoki; Yamamoto, Natsuyo; Tanaka, Yasuo; Yanase, Mikio; Saito, Akiko; Yamada, Kazuhiko; Yokoi, Chizu; Nagahara, Akihito 分享 收藏 Association between skin toxicity and ef fi cacy of necitumumab in squamous non-small-cell lung cancer: a pooled analysis of two randomized clinical trials-SQUIRE and JFCMWatanabe, S.; Yoshioka, H.; Sakai, H.; Hotta, K.; Takenoyama, M.; Yamada, K.; Sugawara, S.; Takiguchi, Y.; Hosomi, Y.; Tomii, K.; Niho, S.; Nishio, M.; Kato, T.; Takahashi, T.; Ebi, H.; Aono, M.; Yamamoto, N.; Ohe, Y.; Nakagawa, K. 分享 收藏 A phase II study of chemotherapy plus local therapy for nonsmall cell lung cancer with oligometastases: TORG1529Saito, Go; Tokito, Taaaki; Ishii, Hidenobu; Takiguchi, Yuichi; Minato, Koichi; Imai, Hisao; Tanaka, Hiroshi; Miura, Satoru; Watanabe, Kageaki; Koreeda, Yoshihusa; Ono, Akira; Furuya, Naoki; Misumi, Toshihiro; Hayakawa, Kazushige; Ogo, Etsuyo; Yamada, Kazuhiko; Okamoto, Hiroaki 分享 收藏 分享 收藏 Phase I study of afatinib plus bevacizumab in patients with advanced non-squamous non-small cell lung cancer harboring EGFR mutations阿法替尼联合贝伐单抗治疗EGFR突变晚期非鳞非小细胞肺癌的I期研究Ko, Ryo; Shukuya, Takehito; Imamura, Chiyo K.; Tokito, Takaaki; Shimada, Naoko; Koyama, Ryo; Yamada, Kazuhiko; Ishii, Hidenobu; Azuma, Koichi; Takahashi, Kazuhisa 分享 收藏 Improved Diagnostic Accuracy of Bone Metastasis Detection by Water-HAP Associated to Non-Contrast CTIshiwata, Yoshinobu; Hieda, Yojiro; Kaki, Soichiro; Aso, Shinjiro; Horie, Keiichi; Kobayashi, Yusuke; Nakamura, Motoki; Yamada, Kazuhiko; Yamashiro, Tsuneo; Utsunomiya, Daisuke 分享 收藏 分享 收藏 Association between soluble immune mediators and tumor responses in patients with nonsmall cell lung cancer treated with anti-PD-1 inhibitorMatsuo, Norikazu; Azuma, Koichi; Hattori, Satoshi; Ohtake, Junya; Kawahara, Akihiko; Ishii, Hidenobu; Tokito, Takaaki; Yamada, Kazuhiko; Shibata, Yuji; Shimokawaji, Tadasuke; Kondo, Tetsuro; Kato, Terufumi; Saito, Haruhiro; Yamada, Kouzo; Sasada, Tetsuro; Hoshino, Tomoaki 分享 收藏 分享 收藏 Successful treatment with an EGFR tyrosine kinase inhibitor Afatinib in a patient with combined small-cell lung Cancer with EGFR mutationEGFR酪氨酸激酶抑制剂阿法替尼成功治疗合并EGFR突变的小细胞肺癌患者Tanaka, Midori; Ishii, Hidenobu; Moribuchi, Hayato; Naito, Yoshiko; Matsuo, Norikazu; Nakamura, Masayuki; Tokito, Takaaki; Azuma, Koichi; Yamada, Kazuhiko; Hoshino, Tomoaki 分享 收藏 E7386, an orally active CBP/beta-catenin modulator, induces T cells infiltration into tumor and enhances antitumor activity of anti-PD-1 mAb in Wnt1 tumor syngeneic mice modelHori, Yusaku; Yamada, Kazuhiko; Kato, Yu; Ozawa, Yoichi; Odagami, Takenao; Matsui, Junji; Matsushima, Tomohiro; Nomoto, Kenichi; Kouji, Hiroyuki; Owa, Takashi 分享 收藏 E7386, an orally active CBP/beta-catenin modulator, effects tumor microenvironment, resulting to the enhancement of antitumor activity of lenvatinibOzawa, Yoichi; Hori, Yusaku; Yamada, Kazuhiko; Funahashi, Yasuhiro; Matsui, Junji; Matsushima, Tomohiro; Owa, Takashi 分享 收藏 E7386: First-in-class orally active CBP/beta-catenin modulator as an anticancer agentYamada, Kazuhiko; Hori, Yusaku; Yamaguchi, Atsumi; Matsuki, Masahiro; Tsukamoto, Shuntaro; Yokoi, Akira; Semba, Taro; Ozawa, Yoichi; Inoue, Satoshi; Yamamoto, Yuji; Iso, Kentaro; Nakamoto, Kazutaka; Harada, Hitoshi; Yoneda, Naoki; Takemura, Atsushi; Matsukura, Masayuki; Kubara, Kenji; Odagami, Takenao; Iwata, Masao; Tsuruoka, Akihiko; Uenaka, Toshimitsu; Matsui, Junji; Matsushima, Tomohiro; Nomoto, Kenich; Kouji, Hiroyuki; Owa, Takashi 分享 收藏 Aplastic anemia in a lung adenocarcinoma patient receiving pemetrexedMatama, Goushi; Tokito, Takaaki; Takeoka, Hiroaki; Hiraoka, Yuki; Matsuo, Norikazu; Nakamura, Masayuki; Ishii, Hidenobu; Kinoshita, Takashi; Azuma, Koichi; Yamada, Kazuhiko; Hoshino, Tomoaki 分享 收藏 Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational studyGoto, Yasushi; Tanai, Chiharu; Yoh, Kiyotaka; Hosomi, Yukio; Sakai, Hiroshi; Kato, Terufumi; Kaburagi, Takayuki; Nishio, Makoto; Kim, Young Hak; Inoue, Akira; Hasegawa, Yoshinori; Isobe, Hiroshi; Tomizawa, Yoshio; Mori, Yoshiaki; Minato, Koichi; Yamada, Kazuhiko; Ohashi, Yasuo; Kunitoh, Hideo 分享 收藏 Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer PatientsMatsuo, Norikazu; Azuma, Koichi; Sakai, Kazuko; Hattori, Satoshi; Kawahara, Akihiko; Ishii, Hidenobu; Tokito, Takaaki; Kinoshita, Takashi; Yamada, Kazuhiko; Nishio, Kazuto; Hoshino, Tomoaki 分享 收藏 Predictive relevance of PD-L1 expression combined with CD8+TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapyTokito, Takaaki; Azuma, Koichi; Kawahara, Akihiko; Ishii, Hidenobu; Yamada, Kazuhiko; Matsuo, Norikazu; Kinoshita, Takashi; Mizukami, Naohisa; Ono, Hirofumi; Kage, Masayoshi; Hoshino, Tomoaki 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
